当前位置:首页 - 行情中心 - 汉森制药(002412) - 财务分析 - 现金流量表

汉森制药

(002412)

  

流通市值:35.75亿  总市值:36.13亿
流通股本:4.98亿   总股本:5.03亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金208,764,792.821,089,832,894.05778,437,939.74546,253,645.98
  收到的税费返还---0
  收到其他与经营活动有关的现金1,420,017.489,180,397.725,594,746.894,491,075.75
  经营活动现金流入小计210,184,810.31,099,013,291.77784,032,686.63550,744,721.73
  购买商品、接受劳务支付的现金41,921,338.97119,544,292.81105,023,117.9473,024,350.17
  支付给职工以及为职工支付的现金77,736,481.89222,254,162.05167,186,844.57115,545,609.73
  支付的各项税费39,606,294.22171,411,781.38130,616,387.15103,710,305.13
  支付其他与经营活动有关的现金61,343,489.75340,421,779.1219,395,116.04148,362,698.42
  经营活动现金流出小计220,607,604.83853,632,015.34622,221,465.7440,642,963.45
  经营活动产生的现金流量净额-10,422,794.53245,381,276.43161,811,220.93110,101,758.28
二、投资活动产生的现金流量:
  收回投资收到的现金394,000,0001,211,613,230.531,138,000,000806,000,000
  取得投资收益收到的现金1,196,679.492,839,808.622,996,369.642,199,250.14
  处置固定资产、无形资产和其他长期资产收回的现金净额-27,305.2427,075.461,775.66
  处置子公司及其他营业单位收到的现金净额---0
  收到的其他与投资活动有关的现金80,506,000218,264.57247,500247,500
  投资活动现金流入小计475,702,679.491,214,698,608.961,141,270,945.1808,448,525.8
  购建固定资产、无形资产和其他长期资产支付的现金3,731,001.2211,103,466.7512,504,370.578,688,480.21
  投资支付的现金470,000,0001,297,209,816.21,261,300,000875,200,000
  质押贷款净增加额---0
  取得子公司及其他营业单位支付的现金---0
  支付其他与投资活动有关的现金-80,000,000-0
  投资活动现金流出小计473,731,001.221,388,313,282.951,273,804,370.57883,888,480.21
  投资活动产生的现金流量净额1,971,678.27-173,614,673.99-132,533,425.47-75,439,954.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金---0
  其中:子公司吸收少数股东投资收到的现金---0
  取得借款收到的现金-56,057,681.2650,000,00050,000,000
  收到其他与筹资活动有关的现金--00
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-56,057,681.2650,000,00050,000,000
  偿还债务支付的现金-83,000,00078,000,00068,000,000
  分配股利、利润或偿付利息支付的现金287,500.031,725,347.241,419,0001,093,458.32
  其中:子公司支付给少数股东的股利、利润---0
  支付其他与筹资活动有关的现金--00
  筹资活动现金流出小计287,500.0384,725,347.2479,419,00069,093,458.32
  筹资活动产生的现金流量净额-287,500.03-28,667,665.98-29,419,000-19,093,458.32
五、现金及现金等价物净增加额-8,738,616.2943,098,936.46-141,204.5415,568,345.55
  加:期初现金及现金等价物余额169,647,573.86126,548,637.4126,548,637.4126,548,637.4
  期末现金及现金等价物余额160,908,957.57169,647,573.86126,407,432.86142,116,982.95
补充资料:
  净利润-198,120,448.74-68,538,438.13
  资产减值准备-3,140,507.13--3,834.07
  固定资产和投资性房地产折旧-39,119,595.57-19,075,283.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-39,119,595.57-19,075,283.82
  无形资产摊销-1,608,795.05-777,330.52
  长期待摊费用摊销-782,338.16-371,525.55
  处置固定资产、无形资产和其他长期资产的损失-15,057.11-448,853.73
  固定资产报废损失-707,885.25-121.46
  公允价值变动损失--1,846,661.4--898,900.83
  财务费用-687,503.22-899,865.74
  投资损失--6,348,190.34-39,497,582.73
  递延所得税--10,531.92--2,787.34
  其中:递延所得税资产减少-180,497.2-127,032.62
    递延所得税负债增加--191,029.12--129,819.96
  存货的减少-13,844,480.96-15,895,670.75
  经营性应收项目的减少--6,373,813.78--18,504,622.58
  经营性应付项目的增加--5,101,444.45--17,569,196.53
  其他----1,092,414.58
  现金的期末余额-169,647,573.86-142,116,982.95
  减:现金的期初余额-126,548,637.4-126,548,637.4
  现金及现金等价物的净增加额-43,098,936.46-15,568,345.55
公告日期2026-04-282026-04-282025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑